Bayer Ascensia recall marked "class I"
This article was originally published in Clinica
Executive Summary
The FDA has slapped a class 1 label - the most serious category - on Bayer Healthcare's recall of its Ascensia Contour blood glucose monitoring system. The company initiated the recall after discovering 16 of the glucose meters, distributed in Canada, had not been adjusted to display the correct measure for Canadian users.